Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

GSK's Jemperli (dostarlimab) Plus Chemotherapy Receives Approval in Singapore for Advanced Endometrial Cancer

Wednesday, August 07, 2024

GSK Singapore has announced that the Singapore Health Sciences Authority HSA has approved a new indication for Jemperli dostarlimab Jemperli is a PDblocking antibody that binds to the PD receptor

Sangamo Therapeutics Enter into Agreement with Genentech for Neurodegenerative Diseases

Wednesday, August 07, 2024

Sangamo Therapeutics a leader in genomic medicine has announced a licensing agreement with Genentech part of the Roche Group to develop intravenously administered genomic treatments for specific neurodegenerative disorders

META Pharmaceuticals Secures FDA Rare Paediatric Disease Designation for META-001-PH

Tuesday, August 06, 2024

META Pharmaceuticals has announced that the US Food and Drug Administration FDA has awarded Rare Paediatric Disease Designation RPDD to its investigational drug METAPH aimed at treating primary hyperoxaluria PH

Ping An-Shionogi Submits New Drug Application for Cefiderocol in China

Tuesday, August 06, 2024

Shionogi announced that Ping AnShionogi has submitted a New Drug Application NDA for cefiderocol to the Center for Drug Evaluation CDE of the NMPA in China This application has now been accepted for review

Antengene Announces XPOVIO® (selinexor) Approved for Use in Malaysia

Tuesday, August 06, 2024

Antengene Corporation has received approval from the Malaysian National Pharmaceutical Regulatory Agency for XPOVIO selinexor XPOVIO is the worlds first oral selective XPO inhibitor and has been approved in eight APAC markets

Formosa Pharmaceuticals and Apotex Enter into Agreement to Commercialise Clobetasol Propionate Ophthalmic Suspension

Tuesday, August 06, 2024

Formosa Pharmaceuticals has announced an exclusive licensing agreement with Apotex for the rights to commercialise clobetasol propionate ophthalmic suspension APP in Canada

Daiichi Sankyo and Merck Expand Global Agreement to Include MK-6070

Tuesday, August 06, 2024

Daiichi Sankyo and Merck have expanded their global codevelopment and cocommercialisation agreement to include Mercks investigational drug MK MK targets DLL a highlevel inhibitor of the canonical Notch ligand expressed in small cell lung cancer

Twist Bioscience and bitBiome Partner to Create Innovative Enzymes for Cutting-Edge Biocatalysis

Monday, August 05, 2024

Twist Bioscience Corporation renowned for its advanced synthetic DNA technology and bitBiome Inc a biotech company specializing in leveraging microbial diversity for the bioeconomy

Labcorp Receives FDA De Novo Approval for PGDx elio™ Plasma Focus Diagnostic Test

Saturday, August 03, 2024

Labcorp has announced that it has obtained De Novo marketing authorization from the US Food and Drug Administration for its PGDx elio plasma focus Dx This test is the first of its kinda kitted

DKSH and Kyowa Kirin Form Strategic Alliance for Expansion in Asia-Pacific

Saturday, August 03, 2024

DKSH Business Unit Healthcare a prominent provider of Market Expansion Services for pharmaceuticals OTC consumer health and medical devices has announced a new strategic partnership with Kyowa Kirin Co Ltd TSE a global specialty pharmaceutical firm b...